Dld Asset Management, LP Cyma Bay Therapeutics, Inc. Transaction History
Dld Asset Management, LP
- $204 Million
- Q3 2024
A detailed history of Dld Asset Management, LP transactions in Cyma Bay Therapeutics, Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 201,100 shares of CBAY stock, worth $0. This represents 0.02% of its overall portfolio holdings.
Number of Shares
201,100Holding current value
$0% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CBAY
# of Institutions
6Shares Held
1.82MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iii, LLC Larkspur, CA1.64MShares$015.17% of portfolio
-
Abingworth LLP London, X0131KShares$00.27% of portfolio
-
Connacht Asset Management LP New York, NY12KShares$01.09% of portfolio
-
Ctc Capital Management, LLC10.7KShares$00.2% of portfolio
-
Pictet Asset Management Sa Geneva 73, V810.6KShares$00.0% of portfolio
About CymaBay Therapeutics, Inc.
- Ticker CBAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,677,904
- Description
- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...